📋About HeartFlow
Updated August 26, 2026HeartFlow applies AI to coronary CT angiography to assess heart disease without an invasive procedure. Its FFR-CT analysis models blood flow through the coronary arteries from a standard CT scan, helping cardiologists decide whether a blockage is significant, and newer products characterize and quantify arterial plaque. HeartFlow's technology is FDA-cleared and reimbursed, making it one of the most established and clinically-validated AI tools in cardiac imaging.
🛠️Products & Tools (1)
HeartFlowMedical Imaging AI
FDA-cleared AI analysis of coronary CT — non-invasive FFR-CT blood-flow assessment and plaque analysis to diagnose heart disease, reimbursed and widely clinically validated.
Keep track of the companies you’re watching
- Save the companies you want to follow
- Get ⚡ alerts when your saved companies change
- Every product they ship, cross-linked to 900+ AI tool profiles
- Today’s top AI Stories — the day’s most important AI news, free
Swipe for Recommended for you and My AI Tools
Your AI Hub — sample data. See desktop view example